Drug interventions and stem cells in traumatic brain injury: Translation from experimental model to bedside
Maha Tabet et al, 2022, Diagnosis and Treatment of Traumatic Brain Injury CrossRef
Edaravone and mitochondrial transfer as potential therapeutics for vanishing white matter disease astrocyte dysfunction
Neville S. Ng et al, 2023, CNS Neuroscience & Therapeutics CrossRef
Synthesis and radioprotective effects of novel hybrid compounds containing edaravone analogue and 3‐n‐butylphthalide ring‐opening derivatives
Xuejiao Li et al, 2021, Journal of Cellular and Molecular Medicine CrossRef
Drug discovery and amyotrophic lateral sclerosis: Emerging challenges and therapeutic opportunities
Pedro Soares et al, 2023, Ageing Research Reviews CrossRef
Traumatic brain injury and immunological outcomes: the double-edged killer
Souvik Datta et al, 2023, Future Science OA CrossRef
Mild traumatic brain injury in Drosophila melanogaster alters reactive oxygen and nitrogen species in a sex-dependent manner
T. Bucky Jones et al, 2024, Experimental Neurology CrossRef
Research Progress and Molecular Mechanisms of Endothelial Cells Inflammation in Vascular-Related Diseases
Jiaojiao Xue et al, 2023, Journal of Inflammation Research CrossRef
Edaravone Improves the Post-traumatic Brain Injury Dysfunction in Learning and Memory by Modulating Nrf2/ARE Signal Pathway
Xiushan Li et al, 2021, Clinics CrossRef
Oxidative stress and mitochondrial dysfunction following traumatic brain injury: From mechanistic view to targeted therapeutic opportunities
Bahareh Hakiminia et al, 2022, Fundamental & Clinical Pharmacology CrossRef
Chromatographic measurement of 3-hydroxyanthranilate 3,4-dioxygenase activity reveals that edaravone can mitigate the formation of quinolinic acid through a direct enzyme inhibition
Ines Sanz et al, 2022, Journal of Pharmaceutical and Biomedical Analysis CrossRef
New Dawn for Atherosclerosis: Vascular Endothelial Cell Senescence and Death
Lan-Lan Bu et al, 2023, International Journal of Molecular Sciences CrossRef